Paclitaxel causes mouse splenic lymphocytes to a state hyporesponsive to lipopolysaccharide stimulation

International Journal of Immunopharmacology

Volumn 22, Issue 8, 2000, Pages 615-621

  Lee, Michael ^a   Yea, Sung Su ^b   Jeon, Young Jin ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Immunosuppression; Lipopolysaccharide; Map kinase; Paclitaxel

Indexed keywords

CONCANAVALIN A; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PACLITAXEL; PROTEIN KINASE; RAF PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE; FEMALE; IMMUNOSUPPRESSIVE AGENTS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PACLITAXEL; PROTO-ONCOGENE PROTEINS C-RAF; SPLEEN;

EID: 0034256963     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(00)00024-2     Document Type: Article

References (27)

1. Rowinsky E.K. Update on the antitumor activity of paclitaxel in clinical trials. Ann. Pharmacother. 28:1994;S18-S22.
2. Saunders D.E., Lawrence W.D., Christensen C., Wappler N.L., Ruan H. Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells. Int. J. Cancer. 70:1997;214-220.
3. Cobb M.H., Goldsmith E.J. How MAP kinases are regulated. J. Biol. Chem. 270:1995;14843-14846.
4. Cano E., Mahadevan L.C. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20:1995;117-122.
5. Stokoe D., Macdonald S.G., Cadwallader K., Symons M., Hancock J.F. Activation of Raf as a result of recruitment to the plasma membrane. Science. 264:1994;1463-1467.
6. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes. Dev. 7:1993;2135-2148.
7. Verheij M., Bose R., Lin X.H., Yao B., Jarvis W.D. Requirement for ceramide-initiated SAPK/JNK signalling in stress- induced apoptosis. Nature. 380:1996;75-79.
8. Kyriakis J.M., Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271:1996;24313-24316.
9. 2-terminal kinase (JNK/SAPK). J. Biol. Chem. 273:1998;28253-28260.
10. Shtil A.A., Mandlekar S., Yu R., Walter R.J., Hagen K., et al. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. Oncogene. 18:1999;377-384.
11. 2-terminal kinase/activator protein 1 pathway and inhibition of extracellular signal-regulated kinase are early effects in paclitaxel-mediated apoptosis in human B lymphoblasts. Cancer. Res. 58:1998;241-247.
12. Manthey C.L., Brandes M.E., Perera P.Y., Vogel S.N. Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages. J. Immunol. 149:1992;2459-2465.
13. Perera P.-Y., Qureshi N., Vogel S.N. Paclitaxel (taxol)-induced NF-κB translocation in murine macrophages. Infect. Immun. 64:1996;878-884.
14. Lee M., Kim H.M., Yang K.H. Down-regulation of protein kinase C in murine splenocytes: a potential mechanism for 2-acetylaminofluorene-mediated immunosuppression. Cancer Lett. 101:1996;53-57.
15. Lee M., Yang K.H., Kaminski N.E. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J. Pharmacol. Exp. Ther. 275:1995;529-536.
16. Ferrier A.F., Lee M., Anderson W.B., Benvenuto G., Morrison D.K. Sequential modification of serines 621 and 624 in the Raf-1 carboxyl terminus produces alterations in its electrophoretic mobility. J. Biol. Chem. 272:1997;2136-2142.
17. Reimann T., Buscher D., Hipskind R.A., Krautwald S., Lohmann-Mattes M.-L. Lipopolysaccharide induces activation of the Raf-1/MAP kinase pathway. J. Immunol. 153:1994;5740-5749.
18. Blagosklonny M.V., Schulte T., Nguyen P., Trepel J., Neckers L.M. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involved c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res. 56:1996;1851-1854.
19. Olah Z., Ferrier A., Lehel C., Anderson W.B. The 33-kDa C-terminal domain of Raf-1 protein kinase exhibits a Ras-independent serum- and phorbol ester-induced shift in gel mobility. Biochem. Biophys. Res. Commun. 214:1995;340-347.
20. Tominaga K., Saito S., Matsuurs M., Nakano M. Lipopolysaccharide tolerance in murine peritoneal macrophages induces downregulation of the lipopolysaccharide signal transduction pathway through mitogen-activated protein kinase and nuclear factor-κB cascades, but not lipopolysaccharide-incorporation steps. Biochim. Biophys. Acta. 1450:1999;130-144.
21. Wang T.H., Wang H.S., Ichijo H., Giannakakou P., Foster J.S. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem. 273:1998;4928-4936.
22. Mullins D.W., Koci M.D., Burger C.J., Elgert K.D. Interleukin-12 overcomes paclitaxel-mediated suppression of T-cell proliferation. Immunopharmacol. Immunotoxicol. 20:1998;473-492.
23. Weinstein S.L., Sanghera J.S., Lemke K., DeFranco A.L., Pelech S.L. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. J. Biol. Chem. 267:1992;14955-14962.
24. Hambleton J., L W.S., Lem L., DeFranco A.L. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl. Acad. Sci. USA. 93 :1996;2774-2778.
25. Manthey C.L., Qureshi N., Stutz P.L., Vogel S.N. Lipopolysaccharide antagonists block taxol-induced signaling in murine macrophages. J. Exp. Med. 178:1993;695-702.
26. Hall-Jackson C.A., Eyers P.A., Cohen P., Goedert M., Boyle F.T. Paradoxical activation of Raf by a novel Raf inhibitor. Chem. Biol. 6:1999;559-568.
27. Franklin C.C., Kraft A.S. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J. Biol. Chem. 272:1997;16917-16923.